A Multicenter, Double-Blind, Palcebo Controlled, Randomized, Efficacy and Safety Study of Denufosol Tetrasodium (INS37217) Inhalation Solution in Patients with Mild Cystic Fibrosis Lung Disease

Grants and Contracts Details

StatusFinished
Effective start/end date2/1/077/31/09

Funding

  • Inspire Pharmaceuticals: $86,760.00